Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
M. Elizabeth Meredith, Therese S. Salameh, William A. Banks
The AAPS Journal (2015) Vol. 17, Iss. 4, pp. 780-787
Open Access | Times Cited: 183

Showing 26-50 of 183 citing articles:

Concepts, technologies, and practices for drug delivery past the blood–brain barrier to the central nervous system
Lindsey Crawford, Justin G. Rosch, David Putnam
Journal of Controlled Release (2015) Vol. 240, pp. 251-266
Closed Access | Times Cited: 70
Role of serum albumin as a nanoparticulate carrier for nose-to-brain delivery of R-flurbiprofen: implications for the treatment of Alzheimer's disease
Ling Rong Wong, Paul C. Ho
Journal of Pharmacy and Pharmacology (2017) Vol. 70, Iss. 1, pp. 59-69
Closed Access | Times Cited: 63
In situ-gelling starch nanoparticle (SNP)/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide
Michael J. Majcher, Ali Babar, Andrew Lofts, et al.
Journal of Controlled Release (2020) Vol. 330, pp. 738-752
Closed Access | Times Cited: 59
The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
Holly C. Hunsberger, Priyanka D. Pinky, Warren E. Smith, et al.
Neuronal Signaling (2019) Vol. 3, Iss. 2
Open Access | Times Cited: 56
Liposomes for drug delivery in stroke
Gisele Eva Bruch, Lorena F. Fernandes, Beatriz Lopes Tecedor Bassi, et al.
Brain Research Bulletin (2019) Vol. 152, pp. 246-256
Open Access | Times Cited: 56
Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders
Elizabeth J. Patharapankal, Adejumoke Lara Ajiboye, Claudia Mattern, et al.
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 66-66
Open Access | Times Cited: 19
PACAP as a neuroprotective factor in ischemic neuronal injuries
Seiji Shioda, Tomoya Nakamachi
Peptides (2015) Vol. 72, pp. 202-207
Open Access | Times Cited: 62
Peripheral Inflammation,Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction
Felecia M. Marottoli, Yuriko Katsumata, Kevin P. Koster, et al.
ASN NEURO (2017) Vol. 9, Iss. 4, pp. 175909141771920-175909141771920
Open Access | Times Cited: 58
Oxytocin and cardioprotection in diabetes and obesity
Marek Jankowski, Tom L. Broderick, Jolanta Gutkowska
BMC Endocrine Disorders (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 56
Current findings on the role of oxytocin in the regulation of food intake
Maartje S. Spetter, Manfred Hallschmid
Physiology & Behavior (2017) Vol. 176, pp. 31-39
Open Access | Times Cited: 54
Peptides as Potential Therapeutics for Alzheimer’s Disease
Samo Ribarič
Molecules (2018) Vol. 23, Iss. 2, pp. 283-283
Open Access | Times Cited: 53
Recent Advances in the Therapeutic and Diagnostic Use of Liposomes and Carbon Nanomaterials in Ischemic Stroke
Lorena F. Fernandes, Gisele Eva Bruch, André Ricardo Massensini, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 53
Intranasal delivery of an antisense oligonucleotide to the RNA-binding protein HuR relieves nerve injury-induced neuropathic pain
Vittoria Borgonetti, Nicoletta Galeotti
Pain (2020) Vol. 162, Iss. 5, pp. 1500-1510
Closed Access | Times Cited: 44
Pharmacokinetics, pharmacodynamics and toxicity of Baicalin liposome on cerebral ischemia reperfusion injury rats via intranasal administration
Xiang Yan, Yu Long, Qiyue Yang, et al.
Brain Research (2019) Vol. 1726, pp. 146503-146503
Closed Access | Times Cited: 43
Lipid-Based Nanocarriers via Nose-to-Brain Pathway for Central Nervous System Disorders
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tran Nguyen Minh An, et al.
Neurochemical Research (2021) Vol. 47, Iss. 3, pp. 552-573
Closed Access | Times Cited: 39
Improvement of Intranasal Drug Delivery with Intravail® Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System
Adrián L. Rabinowicz, Enrique Carrazana, E Maggio
Drugs in R&D (2021) Vol. 21, Iss. 4, pp. 361-369
Open Access | Times Cited: 33
Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges
A Prabakaran, Mukta Agrawal, Mithun Rajendra Dethe, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 1, pp. 87-102
Closed Access | Times Cited: 27
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
Antonella Tramutola, Simona Lanzillotta, Giuseppe Aceto, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 111-111
Open Access | Times Cited: 15
Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective
Sumel Ashique, Obaid Afzal, Sabina Yasmin, et al.
International Journal of Pharmaceutics (2023) Vol. 633, pp. 122614-122614
Closed Access | Times Cited: 13
In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route
Arya Ghosh, Ankit Majie, Varnita Karmakar, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access | Times Cited: 5
Therapeutic effects of orexin-A in sepsis-associated encephalopathy in mice
Jing Guo, Zhuo Kong, Sha Yang, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Comprehensive review of extraction, purification, structural characteristics, pharmacological activities, structure-activity relationship and application of seabuckthorn protein and peptides
Guo Chun-qiu, Ling Na, Haiyan Tian, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139447-139447
Closed Access
Leukemia Inhibitory Factor as a Late-Stage Treatment for Delayed White Matter Loss in Concussive Head Injury
Vivianne Mello, Jelena Mihailovic, Samina Ali, et al.
(2025)
Closed Access
Nanomedicine for Alzheimer's Disease and Their Advanced Therapies
B. Vaishnavi
Advances in medical education, research, and ethics (AMERE) book series (2025), pp. 525-540
Closed Access
On the Relentless Pursuit of an Oral Insulin Delivery System: How Far is Too Far?
Sourav Bhattacharjee
Advanced Therapeutics (2025)
Open Access

Scroll to top